Because Eli Lilly and Company is a widely held, publicly traded corporation on the New York Stock Exchange, no single individual, family, or private entity maintains a majority ownership stake in the enterprise. Instead, the vast majority of the company's outstanding shares are held by massive institutional investment houses, global asset management firms, mutual fund complexes, and retirement funds that manage capital on behalf of millions of individual investors. While descendants of the company's founder, Colonel Eli Lilly, retain historical ties and modest legacy shareholdings, institutional investors collectively dominate the equity distribution.